Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Change in Inventory (2016 - 2025)

STRATA Skin Sciences' Change in Inventory history spans 14 years, with the latest figure at -$282000.0 for Q3 2025.

  • For Q3 2025, Change in Inventory fell 3425.0% year-over-year to -$282000.0; the TTM value through Sep 2025 reached $72000.0, up 107.89%, while the annual FY2024 figure was -$572000.0, 16.98% up from the prior year.
  • Change in Inventory for Q3 2025 was -$282000.0 at STRATA Skin Sciences, down from $535000.0 in the prior quarter.
  • Across five years, Change in Inventory topped out at $1.2 million in Q1 2022 and bottomed at -$898000.0 in Q4 2023.
  • The 5-year median for Change in Inventory is -$132000.0 (2021), against an average of $39684.2.
  • The largest annual shift saw Change in Inventory tumbled 26200.0% in 2021 before it soared 1007.58% in 2022.
  • A 5-year view of Change in Inventory shows it stood at $264000.0 in 2021, then crashed by 204.55% to -$276000.0 in 2022, then plummeted by 225.36% to -$898000.0 in 2023, then skyrocketed by 37.86% to -$558000.0 in 2024, then soared by 49.46% to -$282000.0 in 2025.
  • Per Business Quant, the three most recent readings for SSKN's Change in Inventory are -$282000.0 (Q3 2025), $535000.0 (Q2 2025), and $377000.0 (Q1 2025).